PER percheron therapeutics limited

Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-184

  1. 308 Posts.
    lightbulb Created with Sketch. 863
    @Akki

    Did you listen to the same video as me Akki? I was under the impression she was not complaining about the cost per se. But having a very rational crack at the lack of data. It should be called ghost data.

    Plus, no one how it will work at the 5 year mark. Voit reckons the benefits will wear off reasonably quickly.. maybe because of the inflammation?? And he was one of the 4 inventors.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $727 72.68K

Buyers (Bids)

No. Vol. Price($)
4 2840316 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 3323423 6
View Market Depth
Last trade - 12.00pm 20/06/2025 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.